Neuropeptides (substance P, CGRP, VIP) mediate neurogenic inflammation on the eye surface, contributing to dry eye, allergic conjunctivitis, and corneal wound healing — the neuroimmune basis of ocular surface disease.
Key findingNeuropeptides (substance P, CGRP, VIP) mediate neurogenic inflammation on the eye surface, contributing to dry eye, allergic conjunctivitis, and corne
What the researchers found
Neuropeptides (substance P, CGRP, VIP) mediate neurogenic inflammation on the eye surface, contributing to dry eye, allergic conjunctivitis, and corneal wound healing — the neuroimmune basis of ocular surface disease.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Neurogenic inflammation of the ocular surface.
Current opinion in allergy and clinical immunology, 10(5), 498-504
Citation
Mantelli, Flavio; Micera, Alessandra; Sacchetti, Marta; Bonini, Stefano. (2010). Neurogenic inflammation of the ocular surface.. Current opinion in allergy and clinical immunology, 10(5), 498-504. https://doi.org/10.1097/ACI.0b013e32833e16cc